CAINI, PATRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.408
EU - Europa 2.473
AS - Asia 1.278
SA - Sud America 141
AF - Africa 37
OC - Oceania 37
Totale 8.374
Nazione #
US - Stati Uniti d'America 4.370
RU - Federazione Russa 1.041
SG - Singapore 381
PL - Polonia 346
HK - Hong Kong 302
CN - Cina 288
SE - Svezia 283
IE - Irlanda 255
IT - Italia 154
KR - Corea 125
BR - Brasile 116
DE - Germania 110
FI - Finlandia 77
UA - Ucraina 66
GB - Regno Unito 57
VN - Vietnam 45
TR - Turchia 41
AU - Australia 36
IN - India 35
CI - Costa d'Avorio 24
FR - Francia 23
CA - Canada 21
NL - Olanda 16
BE - Belgio 13
JO - Giordania 13
MX - Messico 13
AR - Argentina 12
CH - Svizzera 8
BD - Bangladesh 7
JP - Giappone 7
IQ - Iraq 6
ID - Indonesia 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
KZ - Kazakistan 3
MA - Marocco 3
NO - Norvegia 3
ZA - Sudafrica 3
AM - Armenia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LT - Lituania 2
PK - Pakistan 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
Totale 8.374
Città #
Santa Clara 1.108
Fairfield 394
Ashburn 384
Warsaw 346
Chandler 280
Dublin 255
Hong Kong 250
Singapore 249
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Beijing 150
Houston 130
Seoul 125
Ann Arbor 115
Jacksonville 102
Buffalo 79
Princeton 61
Los Angeles 57
Altamura 50
Boston 48
Lawrence 45
Boardman 44
The Dalles 42
Dallas 37
Izmir 35
Melbourne 35
Bremen 34
Munich 31
Medford 29
Florence 27
Mumbai 27
Abidjan 24
Shanghai 21
Hefei 20
New York 20
San Jose 20
San Diego 19
Turku 18
Paris 16
Moscow 15
Washington 15
Brussels 13
Falls Church 13
Norwalk 13
Ho Chi Minh City 12
Hanoi 11
Toronto 10
São Paulo 9
Bern 8
Kent 8
London 8
Redondo Beach 8
Brooklyn 7
Tokyo 7
Atlanta 6
Brasília 6
Hillsboro 6
Salerno 6
Stockholm 6
West Jordan 6
Auburn Hills 5
Chicago 5
Clifton 5
Frankfurt Am Main 5
Rio de Janeiro 5
Tashkent 5
Andover 4
Brno 4
Cluj-Napoca 4
Council Bluffs 4
Denver 4
Frankfurt am Main 4
Jakarta 4
Mexico City 4
Rome 4
Baghdad 3
Caserta 3
Dhaka 3
Johannesburg 3
Milan 3
Old Bridge 3
Phoenix 3
Poplar 3
Porto Alegre 3
San Francisco 3
Tianjin 3
Verona 3
Almaty 2
Amman 2
Bastia umbra 2
Belo Horizonte 2
Biên Hòa 2
Bratislava 2
Charlotte 2
Curitiba 2
Da Nang 2
Dehradun 2
Dong Ket 2
Totale 5.744
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 302
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 236
The effects of phosphate on the contraction of single skeletal myofibrils 214
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 200
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 199
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 195
Host genetic determinants in HCV-related mixed cryoglobulinemia 184
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 184
Host genetic determinants in HCV-related mixed cryoglobulinemia 175
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 173
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 171
Analysis of HCV persistence in patients with sustained virological response 170
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 163
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 163
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 162
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 161
Involvement of PI3K in HCV-related lymphoproliferative disorders 152
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 152
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 151
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 151
T(14;18) translocation in chronic hepatitis C virus infection 150
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 148
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 148
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 147
Host genetic determinants in HCV-related mixed cryoglobulinemia 146
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 144
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 141
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 140
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 137
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 137
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 136
Hepatitis C virus core protein enhances B lymphocyte proliferation 134
Crioglobulinemia e linfoma in corso di infezione da HCV 133
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 132
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 126
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 125
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 124
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 124
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 123
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 122
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 121
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 120
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 118
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 115
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 107
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 105
Eventi Oncomolecolari nella Crioglobulinemia Mista 104
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 103
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 99
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 98
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 95
Reply: HCV infection and psychopathological disorders 91
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 84
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 82
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 78
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 77
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 75
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 75
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 73
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 73
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 71
null 48
Totale 8.387
Categoria #
all - tutte 22.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 0 17 37 52 75 45 32
2021/2022431 4 49 15 15 15 17 16 30 21 9 90 150
2022/20231.154 100 152 75 108 114 226 152 59 124 8 21 15
2023/2024363 17 52 68 28 23 66 7 65 8 8 10 11
2024/20252.856 93 286 178 434 966 368 43 171 99 58 90 70
2025/20261.353 353 345 154 114 251 103 33 0 0 0 0 0
Totale 8.387